- Are Solifenacin and Ramosetron Really Ideal to Treat Irritable Bowel Syndrome?: Author's Reply
-
Suzuki H, Matsuzaki
- KMID: 2325961
- J Neurogastroenterol Motil.
- 2012 Oct;18(4):459-459.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Are Solifenacin and Ramosetron Really Ideal to Treat Irritable Bowel Syndrome?
-
Chang FY
- KMID: 2325960
- J Neurogastroenterol Motil.
- 2012 Oct;18(4):457-458.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacokinetics comparison of solifenacin tartrate and solifenacin succinate: a randomized, open-label, single-dose, 2-way crossover study in healthy male volunteers
-
Kim YM, Jeon JY, Moon SJ, Jung J, Son H, Kim MG
- KMID: 2413830
- Transl Clin Pharmacol.
- 2018 Jun;26(2):73-78.
- doi: 10.12793/tcp.2018.26.2.73
Solifenacin is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms. Solifenacin tartrate is a newly developed salt formulation of solifenacin. This study compared the pharmacokinetic and... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial
-
Fukushima , Suzuki H, Matsuzaki , Kiyosue A, Hibi T
- KMID: 2325931
- J Neurogastroenterol Motil.
- 2012 Jul;18(3):317-323.
BACKGROUND/AIMS: Solifenacin, a muscarinic type 3 receptor antagonist, is used to treat overactive bladder in adults. The aim of this study is to examine the efficacy of solifenacin on the... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Solifenacin Succinate for Urinary Difficulty in Brain Lesion: Multicenter Prospective Study
-
Bok SK, Lim JH, Cho KH, Choi ES, Kim SS, Lee YJ, Park NK
- KMID: 2270744
- Brain Neurorehabil.
- 2012 Sep;5(2):75-81.
- doi: 10.12786/bn.2012.5.2.75
OBJECTIVE: We studied the efficacy and safety of solifenacin for urinary difficulty in brain lesion from multicenter prospective study. METHOD: Eighty patients with brain lesion who visited from 5 multicenter department... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of Daytime or Nighttime Dosing with Solifenacin for Overactive Bladder with Nocturia: Impact on Nocturia and Sleep Quality
-
Kwon T, Oh TH, Choi S, Cho WY, Min K, Lee JZ, Moon KH
- KMID: 2385956
- J Korean Med Sci.
- 2017 Sep;32(9):1491-1495.
- doi: 10.3346/jkms.2017.32.9.1491
We compared changes in nocturia and sleep-related parameters between daytime and nighttime solifenacin dosing in patents with overactive bladder (OAB) and nocturia. We comparatively analyzed the data of a 12-week... -
- CITED
-
- Close
- SHARE
-
- Close
- Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder
-
Xu Y, Liu R, Liu C, Cui Y, Gao Z
- KMID: 2396157
- Int Neurourol J.
- 2017 Sep;21(3):212-219.
- doi: 10.5213/inj.1734934.467
PURPOSE: We performed a meta-analysis to evaluate the efficacy and safety of mirabegron add-on therapy to solifenacin for patients with overactive bladder (OAB). METHODS: We conducted a systematic literature review to... -
- CITED
-
- Close
- SHARE
-
- Close
- Antimuscarinic Agent Treatment Affecting Patient-Reported Outcomes in Overactive Bladder Syndrome With Depressive Symptoms
-
Kim KS, Moon HS
- KMID: 2365701
- Int Neurourol J.
- 2016 Dec;20(4):349-355.
- doi: 10.5213/inj.1624678.339
PURPOSE: We investigated improvements in overactive bladder symptoms and depressive symptoms after solifenacin treatment in overactive bladder patients with or without depressive symptoms. METHODS: We performed a prospective study of patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of solifenacin on the improvement of storage symptoms in the early period after photoselective vaporization of the prostate
-
Kim SJ, Bae WJ, Kim SW
- KMID: 2461060
- Investig Clin Urol.
- 2019 Nov;60(6):480-487.
- doi: 10.4111/icu.2019.60.6.480
PURPOSE: We studied the effect of solifenacin on reducing storage symptoms after photoselective vaporization of the prostate (PVP). MATERIALS AND METHODS: This study included patients with persistent storage symptoms of urgency... -
- CITED
-
- Close
- SHARE
-
- Close
- Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms
-
Kosilov KV, Alexandrovich LS, Gennadyevna KI, Viktorovna SO, Sergeevna , Ivanovich
- KMID: 2365718
- Int Neurourol J.
- 2016 Sep;20(3):240-249.
- doi: 10.5213/inj.1632520.260
PURPOSE: The prevalence of hyperactive-type lower urinary tract symptoms is 45.2%, with shares of overactive bladder (OAB) and urge incontinence (UI) symptoms of 10.7% and 8.2%, respectively. We investigated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Factors Associated With Dose Escalation of Solifenacin for the Treatment of Overactive Bladder in Real Life Practice
-
Chun JY, Song M, Han JY, Na S, Hong B, Choo MS
- KMID: 2232917
- Int Neurourol J.
- 2014 Mar;18(1):23-30.
PURPOSE: To determine the baseline clinical characteristics associated with dose escalation of solifenacin in patients with overactive bladder (OAB). METHODS: We analyzed the data of patients with OAB (micturition frequency >... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Tolerability of Solifenacin 5 mg Fixed Dose in Korean Children with Newly Diagnosed Idiopathic Overactive Bladder: a Multicenter Prospective Study
-
Lee SD, Chung JM, Kang DI, Ryu DS, Cho WY, Park S
- KMID: 2364179
- J Korean Med Sci.
- 2017 Feb;32(2):329-334.
- doi: 10.3346/jkms.2017.32.2.329
We investigated the efficacy and tolerability of solifenacin 5 mg fixed dose in children with newly diagnosed idiopathic overactive bladder (OAB). A total of 34 children (male/female patients = 16/18)... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in attention variables in those who treated with anticholinergic agents for nonmonosymptomatic enuresis
-
Jang G, Im YJ, Suh J, Park K
- KMID: 2471077
- Investig Clin Urol.
- 2020 Mar;61(2):207-215.
- doi: 10.4111/icu.2020.61.2.207
PURPOSE: Brain dysfunction related to areas regarding attention and arousal may occur not only in patients with attention-deficit/hyperactivity disorder (ADHD) but also in patients with enuresis and daytime symptoms. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial
-
Elbaset MA, Taha DE, El-Hefnawy AS, Zahran MH, Shokeir AA
- KMID: 2460737
- Int Neurourol J.
- 2019 Sep;23(3):240-248.
- doi: 10.5213/inj.1938098.049
PURPOSE: To evaluate the efficacy and safety of re-treatment with anticholinergics on refractory idiopathic overactive bladder (OAB) previously treated with intravesical botulinum neurotoxin type A (BTX-A) injections. METHODS: One hundred patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of the Short-term Intake of High Doses of Solifenacin and Trospium on Cognitive Function and Health-Related Quality of Life in Older Women With Urinary Incontinence
-
Kosilov K, Kuzina I, Loparev S, Gainullina Y, Kosilova L, Prokofyeva A
- KMID: 2409726
- Int Neurourol J.
- 2018 Mar;22(1):41-50.
- doi: 10.5213/inj.1834996.498
PURPOSE: The aim of this study was to investigate the safety and the effects of elevated doses of solifenacin and trospium on cognitive function and health-related quality of life (HRQoL)... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Tamsulosin, Solifenacin, and Combination Therapy for the Treatment of Ureteral Stent Related Discomforts
-
Lim KT, Kim YT, Lee TY, Park SY
- KMID: 2315443
- Korean J Urol.
- 2011 Jul;52(7):485-488.
PURPOSE: To evaluate the effect of tamsulosin, solifenacin, and combination therapy of two agents in improving the lower urinary tract symptoms of patients with indwelling double-J ureteral stents. MATERIALS AND METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function
-
Seo DH, Kam SC, Hyun JS
- KMID: 2315650
- Korean J Urol.
- 2011 Jan;52(1):49-54.
PURPOSE: To examine the effects on erectile function of concomitant treatment with an alpha-blocker (tamsulosin) and an antimuscarinic agent (solifenacin) in patients with lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study
-
Choi H, Bae JH, Oh CY, Jeong SJ, Ko WJ, Choi JB, Seo JT, Lee DH, Kim JC, Lee KW, Kim YH
- KMID: 2409727
- Int Neurourol J.
- 2018 Mar;22(1):51-57.
- doi: 10.5213/inj.1834982.491
PURPOSE: To compare the clinical efficacy of anticholinergics for managing diabetes mellitus-associated overactive bladder (DM OAB) versus idiopathic overactive bladder (OAB) in Korean women. METHODS: We conducted a multicenter, prospective, parallel-group,... -
- CITED
-
- Close
- SHARE
-
- Close
- Review of the Anticholinergics for the Treatment of Overactive Bladder: 2009 Update
-
Oh SJ
- KMID: 2331537
- J Korean Continence Soc.
- 2009 Jun;13(1):7-22.
Overactive bladder is a chronic condition defined by bothersome urgency with or without urgency incontinence, usually associated with daytime frequency and nocturia. The treatment of this condition is to control... -
- CITED
-
- Close
- SHARE
-
- Close
- Characterization of Bladder Selectivity of Antimuscarinic Agents on the Basis of In Vivo Drug-Receptor Binding
-
Yamada S, Kuraoka S, Osano A, Ito Y
- KMID: 2232961
- Int Neurourol J.
- 2012 Sep;16(3):107-115.
The in vivo muscarinic receptor binding of antimuscarinic agents (oxybutynin, solifenacin, tolterodine, and imidafenacin) used to treat urinary dysfunction in patients with overactive bladder is reviewed. Transdermal administration of oxybutynin... -
- CITED
-
- Close
- SHARE
-
- Close
